Skip to content
healthcare.dev

Naprelan

NDC 24979-249, Naproxen Sodium, tablet, film coated, extended release, from Upsher-Smith Laboratories, LLC.

Product NDC
24979-249
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24979-249 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM375 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
24979-249-0124979024901100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-249-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b8a51c9a-488e-4377-a041-436f6a2f8893

Use it

Look up 24979-249 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24979-249 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24979-249. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.